Detalhe da pesquisa
1.
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Br J Cancer
; 130(6): 961-969, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272963
2.
Impact of the Sars-Cov-2 outbreak on the initial clinical presentation of new solid cancer diagnoses: a systematic review and meta-analysis.
BMC Cancer
; 24(1): 143, 2024 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287348
3.
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort.
Liver Int
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588031
4.
No changes in clinical presentation, treatment strategies and survival of pancreatic cancer cases during the SARS-COV-2 outbreak: A retrospective multicenter cohort study on real-world data.
Int J Cancer
; 153(12): 1988-1996, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539961
5.
External Validity of Two Scores for Predicting the Risk of Chemotherapy Toxicity Among Older Patients With Solid Tumors: Results From the ELCAPA Prospective Cohort.
Oncologist
; 28(6): e341-e349, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37027521
6.
Two-part joint model for a longitudinal semicontinuous marker and a terminal event with application to metastatic colorectal cancer data.
Biostatistics
; 23(1): 50-68, 2022 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32282877
7.
Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial.
J Natl Compr Canc Netw
; 21(12): 1234-1242.e17, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38081120
8.
Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review.
Health Qual Life Outcomes
; 21(1): 11, 2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721272
9.
Bayesian estimation of two-part joint models for a longitudinal semicontinuous biomarker and a terminal event with INLA: Interests for cancer clinical trial evaluation.
Biom J
; 65(4): e2100322, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36846925
10.
Generalized pairwise comparisons for censored data: An overview.
Biom J
; 65(2): e2100354, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36127290
11.
Development of a natural language processing model for deriving breast cancer quality indicators : A cross-sectional, multicenter study.
Rev Epidemiol Sante Publique
; 71(6): 102189, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972522
12.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390339
13.
Impact of two waves of Sars-Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: A French multicentric cohort study from a large group of university hospitals.
Int J Cancer
; 150(10): 1609-1618, 2022 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35001364
14.
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.
Int J Cancer
; 151(11): 1978-1988, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833561
15.
Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histology.
J Hepatol
; 77(1): 116-127, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35143898
16.
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma.
J Hepatol
; 77(6): 1586-1597, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987274
17.
Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials.
Clin Trials
; 18(1): 51-60, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998522
18.
Impact on Health-Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial.
Oncologist
; 25(5): e843-e851, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32212354
19.
Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma.
Int J Cancer
; 144(4): 886-896, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30155929
20.
Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey.
Oncologist
; 24(12): e1351-e1359, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31324663